Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action

NCT05548075 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05548075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05548075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Unknown status
Start date
August 15, 2022
Completion date
July 30, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia